数字吸入器粘附技术在难以治疗的喘中的长期成本效益
Susanne J van de Hei1, Chong H Kim2, Persijn J Honkoop3
1Department of Health Sciences, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands; Groningen Research Institute for Asthma and COPD (GRIAC), University of Groningen, University Medical Center Groningen, Groningen, The Netherlands; General Practitioners Research Institute, Groningen, The Netherlands.
概括
数字吸入器通过提高附着性和降低生物成本,为难以治疗的喘提供长期的成本节省. 这项技术优化了治疗并提高了患者的治疗结果,使其成为一种有价值的医疗保健投资.
科学领域:
- 卫生经济学 卫生经济学
- 呼吸系统医学 呼吸系统医学
- 数字健康数字健康
背景情况:
- 数字吸入器可以监控使用情况并帮助喘管理,但其经济价值尚不清楚,这阻碍了广泛采用.
- 难以治疗的喘需要优化管理策略,以改善患者的治疗结果并减少医疗负担.
研究的目的:
- 评估数字吸入器在难以治疗的喘治疗中的长期成本效益.
- 评估基于数字吸入器的药物坚持管理对经济的影响.
主要方法:
- 一个基于模型的成本效益分析,使用马尔科夫模型,根据临床理解和基于指南的评估进行评估.
- 纳入随机临床试验数据 (INCA Sun) 和通过AdViSHE工具进行验证.
- 评估长期临床情景,包括减少恶化,改善喘控制和生物类似药的引入.
主要成果:
- 数字吸入器证明了长期的成本节约,10年的干预比常规护理节省了每位患者26,309欧元.
- 数字吸入器的初始生物治疗成本 (49%) 与通常护理 (69%) 相比较低.
- 场景分析始终显示成本节约,每名患者的成本节约从2,287欧元到4,581欧元不等.
结论:
- 从长远来看,数字吸入器干预可以节省难以治疗的喘的成本.
- 优化药物坚持和吸入器技术减少了对昂贵的附加生物处方的需求.
- 数字吸入器代表了一种具有成本效益的策略,用于改善喘管理和患者的治疗结果.
相关概念视频
01:23Inhaled Medications
319
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
319
01:30Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
01:26COPD: Management Using Bronchodilators and Corticosteroids
250
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
250
01:25Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
309
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
309
01:29Chronic Obstructive Pulmonary Disease-V: Management
2.6K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.6K
01:25Antiasthma Drugs: β2-Adrenoceptor Agonists
314
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
314